G-4 (drug)
Pharmaceutical compound
From Wikipedia, the free encyclopedia
G-4, also known as 3,4-tetramethylene-2,5-dimethoxyamphetamine or as 6-(2-aminopropyl)-5,8-dimethoxytetralin, is a chemical compound of the phenethylamine, amphetamine, and DOx families.[1][2] It is one of several homologues of Ganesha (G).[1][2]
administrationUnknown[1]
- None
| Clinical data | |
|---|---|
| Other names | G4; Ganesha-4; GANESHA-4; 3C-G-4; 3,4-Tetramethylene-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-3,4-(tetramethylene)amphetamine; 6-(2-Aminopropyl)-5,8-dimethoxytetralin; DOG-4 |
| Routes of administration | Unknown[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C15H23NO2 |
| Molar mass | 249.354 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists G-4's dose as unknown and its duration as unknown.[1][2] He was unable to complete the last step of its chemical synthesis and did not test it or determine its properties and effects.[1] The chemical synthesis of G-4 has been described.[1]
G-4 was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[3]